Cite
HARVARD Citation
Gwin, W. et al. (2017). Use of the TLR2 ligand polysaccharide krestin to maximize conventional cancer therapy. Expert review of quality of life in cancer care. 2 (3), pp. 133-135. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gwin, W. et al. (2017). Use of the TLR2 ligand polysaccharide krestin to maximize conventional cancer therapy. Expert review of quality of life in cancer care. 2 (3), pp. 133-135. [Online].